An oral solution for treating hyperthyroidism in cats has been launched by Norbrook.
Thyronorm Oral Solution for Cats is a liquid alternative to tablets and is licensed for the long-term treatment of feline hyperthyroidism and the stabilisation of hyperthyroidism in cats prior to surgical thyroidectomy.
The flavoured liquid formulation contains 5mg/ml of thiamazole, which is proven to have in vivo bioequivalence to thiamazole-containing tablets.
It is specifically designed to increase compliance and improve titration ability for precise, accurate management of hyperthyroid cats, while the added honey allows for even greater pet acceptance, thereby helping maintain the pet-owner bond, the company said.
The initial starting dose is 5mg active ingredient per day, ideally split into two doses and made simple with a clearly marked dosing syringe. The syringe is marked in milligrams of active ingredient to ensure accurate dosing depending on the individual pet’s requirement.
Available in 30ml and 100ml bottles, and with an in-use shelf life of six months, Thyronorm provides a simple solution to stabilising hyperthyroid cats prior to surgery or radioiodine therapy – and can provide a solution for owners wanting to continue medication treatment long term.
Thyronorm Oral Solution for Cats is available to order from UK veterinary wholesalers.